Table 1 Patient characteristics during treatment with placebo

Sex

Men (n, %)

23 (74%)

Women (n, %)

8 (26%)

Age (years)

60 (55-63)

BMI (kg/m²)^a

30.7 (27.7–32.2)

Waist circumference (cm)^a

Men

111 (107–116)

Women

98 (95–99)

Office blood pressure (mmHg)

Systolic

153 (145–167)

Diastolic

88 (84–96)

24-h blood pressure (mmHg)

Systolic

131 (124–144)

Diastolic

80 (76–87)

Heart rate (beats/min)

71 (69–79)

MSNA (bursts/min)

46 (39–50)

Sodium intake (mmol/day)

87 (58–118)

Fasting glucose (mmol/L)

5.6 (5.0–6.0)

Total cholesterol (mmol/L)

5.7 (5.1–6.2)

HDL-cholesterol (mmol/L)

Men

1.02 (0.94–1.22)

Women

1.31 (1.28–1.76)

Triglycerides (mmol/L)

1.90 (1.40–2.30)

hsCRP (mg/L)

1.8 (1.3–3.3)

eGFR (ml/min/1.73m²)

79 (73–86)

Renin (pg/ml)

57.2 (42.4–79.4)

Aldosterone (pg/ml)

53.4 (33.2–76.4)

Adiponectin (μg/ml)

68.9 (51.9–104.1)

Leptin (ng/ml)

16.4 (9.5–33.2)